Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma
about
New advances in hepatocellular carcinomaGenetic alterations in hepatocellular carcinoma: An updateTelomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysisHepatitis C virus and hepatocarcinogenesisFunctional short tandem repeat polymorphism of PTPN11 and susceptibility to hepatocellular carcinoma in Chinese populationsRisk prediction models for hepatocellular carcinoma in different populations.Next generation sequencing gives an insight into the characteristics of highly selected breeds versus non-breed horses in the course of domestication.Viral hepatitis and hepatocellular carcinoma: etiology and managementGenetic polymorphisms are associated with the risk of gastric and colorectal cancers in a Han Chinese population.Variants identified by hepatocellular carcinoma and chronic hepatitis B virus infection susceptibility GWAS associated with survival in HBV-related hepatocellular carcinoma.Pathways of distinction analysis: a new technique for multi-SNP analysis of GWAS data.A 3' UTR SNP in COL18A1 is associated with susceptibility to HBV related hepatocellular carcinoma in Chinese: three independent case-control studiesAssociations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma riskThe 3' UTR variants in the GRP78 are not associated with overall survival in resectable hepatocellular carcinoma.Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci in a Chinese population.Hepatocellular carcinoma: clinical frontiers and perspectives.Loss of heterozygosity at D8S262: an early genetic event of hepatocarcinogenesis.CASP 3 genetic polymorphisms and risk of Hepatocellular carcinoma: a case-control study in a Chinese population.Unrecognized sequence homologies may confound genome-wide association studies.Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma.A functional insertion/deletion polymorphism in the proximal promoter of CD3G is associated with susceptibility for hepatocellular carcinoma in Chinese population.Genetic variations in STAT4,C2,HLA-DRB1 and HLA-DQ associated with risk of hepatitis B virus-related liver cirrhosis.Germline DNA copy number variation in familial and early-onset breast cancerProgrammed death-1 (PD-1) rs2227981 C > T polymorphism is associated with cancer susceptibility: a meta-analysis.Individualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategies.Combined effects of p53 and MDM2 polymorphisms on susceptibility and surgical prognosis in hepatitis B virus-related hepatocellular carcinoma.Human leukocyte antigens and epstein-barr virus-associated nasopharyngeal carcinoma: old associations offer new clues into the role of immunity in infection-associated cancers.Promoter polymorphisms of DNA methyltransferase 3B and risk of hepatocellular carcinoma.Association of the GLB1 rs4678680 genetic variant with risk of HBV-related hepatocellular carcinoma.Multi-ethnic studies in complex traits.Germline copy number variations and cancer predisposition.Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside.Update on biomarkers of hepatocellular carcinoma.Genome-wide association studies of cancer in diverse populations.Systematical analyses of variants in DNase I hypersensitive sites identified two novel hepatocellular carcinoma susceptibility loci among Chinese population.Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma.Genome-wide association studies: inherent limitations and future challenges.Genetic variants in cell death pathway genes and HBV-related hepatocellular carcinoma among a Chinese Han population.Application of Machine Learning to Development of Copy Number Variation-based Prediction of Cancer RiskAssociation of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
P2860
Q26749329-56EB89F2-6557-4FDE-A284-BC3CB72F2EBBQ28073241-7849FDA8-14BB-4E74-AE46-9263A0F68149Q28265076-F9726EC1-C85B-44F5-8E05-A065F95724A0Q28283484-B5E44518-F9D8-4608-AF12-BA7D884FB3D3Q28542875-D3B8F78B-4BEF-4BBD-A5BE-D75641CF0668Q30383460-3BA3E548-0287-4EE7-8D7B-D5D3B66D1A5AQ30583662-7D4A370F-CE7D-4B04-B112-A18AAC6DD480Q33593219-D26AE552-7875-402E-85A1-115065127C79Q33709900-4B8C50EC-16AE-4F13-AC54-8C5405A5BAE3Q33838461-3F6FD5F9-6E22-4CFC-9FEA-1418575A3340Q33939800-6150C2D3-2972-4DE6-A42A-FDAF99A77D91Q34213827-B6523C1F-B2C3-4733-A65F-36A465BF0A5BQ34629791-817410EF-F25C-4355-8BEC-8DF21F3E7F58Q34708309-2E7CEB3B-73ED-4475-A664-3D3EFBCB3CFDQ35035182-E3E3D01C-C0CB-4E09-929D-CFD7DBB61D4FQ35112053-C59550B7-8C2F-45B0-A1A9-F09AA4C9B302Q35747284-2889C829-A59B-499F-A229-08FC84599BF7Q35892035-5246ECD2-83C6-46B8-9C46-94856C00E065Q36008184-A6847D61-CFE1-45F4-807D-9395F460CDABQ36189699-70D5012A-7F94-463A-9DC3-B9B2764FAD5AQ36194154-F7F64821-B7D1-4893-A228-55B9E5A04A38Q36250066-C238D20A-1C88-46D1-804F-6CE53EE37629Q36393187-F9AB37D0-FBEE-4859-985A-EFFBE85F6F0FQ36511487-69ECA924-F030-4B76-A0D5-EE4321A3FFEEQ36699256-E846B056-C973-4C85-84F3-063439E26125Q36923010-3D400111-B832-4C6D-AA61-1640CEA00C1BQ37376994-36DFA62C-DC33-4B2D-ACFE-961A8E594A33Q37565314-B8054685-FC04-4FA4-8318-CBDD45C11A25Q37636659-2D45E4E6-18F8-413B-920A-358465629F9CQ37926264-7DFD087B-2256-43A6-8AE2-117CA3519D6DQ38003668-9894433A-3ED9-4A30-A7D5-BB1CB2CC9398Q38046452-7317A00B-9884-4A84-B260-9CB01259901DQ38166133-26DEA197-A915-4E68-BAF2-6BBC10570E07Q38668307-8422AD88-03C9-48C3-9502-783858896D77Q38891805-9CA8EE9A-16E8-4839-B0D8-26620B425046Q39471805-960C854A-56BA-4A83-B89B-191178C4B0E2Q39525714-8561E39B-DB7F-40F9-A37E-FB331A2ABBCCQ40148580-B033CEF7-3A1C-4829-9189-BAAAB54ED6B9Q41715498-AD94F640-45BF-41DD-B154-17EC121EB685Q42223486-866BCFCC-CE99-436C-93F4-57759E47586F
P2860
Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma
description
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2010
@ast
im Dezember 2010 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
wetenschappelijk artikel (gepubliceerd op 2010/12/01)
@nl
наукова стаття, опублікована в грудні 2010
@uk
مقالة علمية (نشرت في ديسمبر 2010)
@ar
name
Genetic variations at loci inv ...... s for hepatocellular carcinoma
@ast
Genetic variations at loci inv ...... s for hepatocellular carcinoma
@en
type
label
Genetic variations at loci inv ...... s for hepatocellular carcinoma
@ast
Genetic variations at loci inv ...... s for hepatocellular carcinoma
@en
prefLabel
Genetic variations at loci inv ...... s for hepatocellular carcinoma
@ast
Genetic variations at loci inv ...... s for hepatocellular carcinoma
@en
P2093
P3181
P356
P1433
P1476
Genetic variations at loci inv ...... s for hepatocellular carcinoma
@en
P2093
Chunhua Yan
Constance M. Cultraro
Cu V. Nguyen
Daoud M. Meerzaman
Hongen Zhang
Il Han Song
Jenny M. Kelley
Jeong A. Kim
Jinghui Zhang
P304
P3181
P356
10.1002/HEP.23943
P407
P50
P577
2010-12-01T00:00:00Z